PLASMA HALF-LIFE AND URINARY-EXCRETION OF CYCLOPHOSPHAMIDE IN CHILDREN
- 1 January 1980
- journal article
- research article
- Vol. 64 (10-1) , 1061-1066
Abstract
The plasma half-life and urinary excretion of cyclophosphamide were determined in 13 children who had various malignancies and/or who were being prepared for bone marrow transplantation. Disappearance from the plasma following i.v. infusion over a 1-2 h period was 1st-order. Urinary excretion was maximal during the first 8 h after administration and was essentially complete in 24 h. The plasma half-life in children not receiving known inducers of hepatic microsomal mixed-function oxygenase activity or cyclophosphamide in the 3 wk period prior to each determination ranged from 145-390 min. These values are lower than those ordinarily found in adult patients. The fraction of the total dose excreted in the urine as the parent compound ranged from 4-27%. Repeated administration of cyclophosphamide at approximately 30-60 day intervals did not appear to alter its plasma half-life, but did appear to increase its urinary excretion. Daily administration of cyclophosphamide (.apprx. 50 mg/kg per day .times. 2 or 4) significantly decreased its plasma half-life and urinary excretion suggesting that it may reversibly induce its own metabolism.This publication has 11 references indexed in Scilit:
- Decreased hepatic drug demethylation in patients receiving chemo-immunotherapyCancer, 1978
- MICROSOMAL-ENZYMES IN PATIENTS WITH GASTRIC CARCINOMA AS DETERMINED BY PLASMA HALF-LIFE OF ANTIPYRINE1978
- DIFFERENTIAL EFFECTS OF WALKER 256 CARCINOSARCOMA CELLS GROWING SUBCUTANEOUSLY, INTRAMUSCULARLY, OR INTRA-PERITONEALLY ON HEPATIC MICROSOMAL MIXED-FUNCTION OXYGENASE ACTIVITY1978
- QUANTITATION BY GAS CHROMATOGRAPHY CHEMICAL IONIZATION MASS-SPECTROMETRY OF CYCLOPHOSPHAMIDE, PHOSPHORAMIDE MUSTARD, AND NORNITROGEN MUSTARD IN PLASMA AND URINE OF PATIENTS RECEIVING CYCLOPHOSPHAMIDE THERAPY1978
- Effect of Phenobarbital on Cyclophosphamide Cytotoxic Activity and Pharmacokinetics in MiceTumori Journal, 1977
- METABOLIC DISPOSITION OF ANTIPYRINE IN PATIENTS WITH LUNG-CANCER1977
- Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath testJAMA, 1976
- The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamideCancer, 1976
- STUDIES OF EFFECTS OF CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE ON SOME HEPATIC OXIDATIONS AND CONJUGATIONS1976
- Quantitative Assessment of Hepatic Function by Breath Analysis after Oral Administration of [^14C]aminopyrineAnnals of Internal Medicine, 1975